U.S. researchers using a biochemical test found that the malaria parasite attaches to the EBL-1 molecule on glycophorin B found on the surface of human red blood cells. "Down the road, the EBL-1 molecule could be used as a vaccine target against malaria as part of a multivalent vaccine, or vaccine cocktail," the lead researcher said.

Related Summaries